Getinge/Castle, Inc., a worldwide supplier of disinfection, sterilization and surgical equipment has announced a new Corporate Sales Team. Carlton B. Colclough has been named Vice President, Corporate Sales and will lead the new team.
Colclough takes over an established corporate sales program. He will enhance and refocus Getinge/Castle's efforts in a changing corporate accounts environment as purchasing groups redefine their delivery methods, including e-commerce initiatives.
Colclough comes to Getinge/Castle from Olympus America and previously held positions with Ohmeda, Inc.; Amsco International; Will Ross Inc.'s Health Group; and Kendall Company. In addition to his duties with Getinge/Castle, Colclough will be responsible for all government and corporate accounts for Arjo, Inc. and Pegasus Airwave, Inc., divisions of parent company Getinge Industrier, AB, as they relate to the acute care market.
Robert K. Anderson and Gregory W. Patric have also joined the corporate sales team, serving as corporate sales directors.
Anderson comes to Getinge/Castle after 20 years in the healthcare field with Standard Register Company, HCA, Voluntary Hospitals of America and Health One. Patrick comes to Getinge/Castle from Executone Healthcare Systems, Inc. and has worked for Hill-Rom, and Amsco. Anderson and Patrick will be responsible for various group purchasing organizations and integrated healthcare delivery networks throughout the United States.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.